Tirzepatide (Dual GIP/GLP-1)
Tirzepatide is a prescription medication that activates both the
GIP and GLP-1 receptors. It is used for chronic weight management
and type 2 diabetes and has demonstrated substantial weight-loss
benefits when combined with lifestyle changes under physician
supervision.
Clinics in Bangalore
Avataar Clinic
Publicly advertises Tirzepatide (Mounjaro) medical weight-loss programs.
Clinic Living Plus
Functional medicine and longevity clinic with physician-led obesity management.
Venkat Center for Aesthetic Health
Offers supervised medical weight-loss services and GLP-1 based programs.
ProGen Weight Management
Dedicated weight-loss center offering physician-guided obesity treatment.
Treatment Information
- Evidence: High for medically indicated obesity treatment.
- Administration: Once-weekly injection.
- Downtime: None.
- Typical Duration: Several months or longer depending on clinical goals.
- Estimated Monthly Cost (India): ₹14,000–₹25,000+ depending on dose and provider.
Common Uses
- Medical weight loss
- Obesity management
- Type 2 diabetes treatment (when indicated)
- Metabolic risk reduction under physician supervision
Important:
Tirzepatide is a prescription medication and should only be started
after evaluation by a qualified healthcare professional. Eligibility,
dosing, contraindications, and monitoring requirements vary by patient.
← Back to Fromenta